Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
37,163,707
-
Share change
-
-703,541
-
Total reported value
-
$4,512,702,432
-
Put/Call ratio
-
98%
-
Price per share
-
$121.45
-
Number of holders
-
350
-
Value change
-
-$68,301,545
-
Number of buys
-
188
-
Number of sells
-
141
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2025
As of 30 Sep 2025,
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by
350 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,163,707 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, MACQUARIE GROUP LTD, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., STATE STREET CORP, and FMR LLC.
This page lists
350
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.